74H.F · HEXO Corp

-

Please sign in to comment on 74H.F

1 Comment

Admin

4 years, 1 month ago

HEXO Corp is currently in a long term uptrend where the price is trading 30.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.

HEXO Corp's total revenue rose by 103.2% to $29M since the same quarter in the previous year.

Its net income has increased by 93.3% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 89.7% to $-8M since the same quarter in the previous year.

Based on the above factors, HEXO Corp gets an overall score of 5/5.

ISIN	CA4283044069
Exchange	F
CurrencyCode	EUR
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Beta	2.37
Market Cap	107M
PE Ratio	None
Target Price	None
Dividend Yield	None

ABOUT

HEXO Corp

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.

74H.F · HEXO Corp

-

HEXO Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest HEXO Corp using a moving average strategy